Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1996 Sep;75(3):191–193. doi: 10.1136/adc.75.3.191

Head growth in cystic fibrosis following early diagnosis by neonatal screening.

S Ghosal 1, C J Taylor 1, M Pickering 1, J McGaw 1
PMCID: PMC1511694  PMID: 8976655

Abstract

Growth in length, weight gain, and head circumference were recorded from 3 months to 4 years of age in 25 children with cystic fibrosis diagnosed by neonatal screening. Mean standard deviation (SD) scores at 3 months for length, weight, and head circumference were -0.78, -0.91, and -0.52 respectively. Over the first 2 years length SD scores showed a consistent improvement and stabilised at 0.1 SD below mean from 2 to 4 years. Weight SD scores remained essentially unaltered throughout, approximately 1 SD below the mean. Head circumference, however, after an initial increase from -0.52 at 3 months to -0.25 at 18 months, slowed and fell to 1 SD below the mean at 4 years. The data suggest that head growth continues to lag behind somatic growth in children with cystic fibrosis despite early diagnosis and good nutritional management in early infancy. These data also support functional expression of cystic fibrosis transmembrane conductance regulator in the brain.

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballesteros M. C., Hansen P. E., Soila K. MR imaging of the developing human brain. Part 2. Postnatal development. Radiographics. 1993 May;13(3):611–622. doi: 10.1148/radiographics.13.3.8316668. [DOI] [PubMed] [Google Scholar]
  2. Blatter D. D., Bigler E. D., Gale S. D., Johnson S. C., Anderson C. V., Burnett B. M., Parker N., Kurth S., Horn S. D. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol. 1995 Feb;16(2):241–251. [PMC free article] [PubMed] [Google Scholar]
  3. Bronstein M. N., Sokol R. J., Abman S. H., Chatfield B. A., Hammond K. B., Hambidge K. M., Stall C. D., Accurso F. J. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr. 1992 Apr;120(4 Pt 1):533–540. doi: 10.1016/s0022-3476(05)82478-3. [DOI] [PubMed] [Google Scholar]
  4. Chatfield S., Owen G., Ryley H. C., Williams J., Alfaham M., Goodchild M. C., Weller P. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child. 1991 Jan;66(1 Spec No):29–33. doi: 10.1136/adc.66.1_spec_no.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dorin J. R., Dickinson P., Alton E. W., Smith S. N., Geddes D. M., Stevenson B. J., Kimber W. L., Fleming S., Clarke A. R., Hooper M. L. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature. 1992 Sep 17;359(6392):211–215. doi: 10.1038/359211a0. [DOI] [PubMed] [Google Scholar]
  6. Ghosal S., Taylor C. J., Pickering M., McGaw J., Beckles-Willson N., Wales J. K. Disproportionate head growth retardation in cystic fibrosis. Arch Dis Child. 1995 Feb;72(2):150–152. doi: 10.1136/adc.72.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Graham G. G. Effect of infantile malnutrition on growth. Fed Proc. 1967 Jan-Feb;26(1):139–143. [PubMed] [Google Scholar]
  8. Karlberg J., Kjellmer I., Kristiansson B. Linear growth in children with cystic fibrosis. I. Birth to 8 years of age. Acta Paediatr Scand. 1991 May;80(5):508–514. doi: 10.1111/j.1651-2227.1991.tb11894.x. [DOI] [PubMed] [Google Scholar]
  9. Lee J. A., Dickinson L. S., Kilgore B. S., Warren R. H., Elders M. J. Somatomedin activity in cystic fibrosis and reserpinized rats: possible explanation for growth retardation. Ann Clin Lab Sci. 1980 May-Jun;10(3):227–233. [PubMed] [Google Scholar]
  10. Mulberg A. E., Resta L. P., Wiedner E. B., Altschuler S. M., Jefferson D. M., Broussard D. L. Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain. J Clin Invest. 1995 Jul;96(1):646–652. doi: 10.1172/JCI118080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ranieri E., Ryall R. G., Morris C. P., Nelson P. V., Carey W. F., Pollard A. C., Robertson E. F. Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis. BMJ. 1991 May 25;302(6787):1237–1240. doi: 10.1136/bmj.302.6787.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Snouwaert J. N., Brigman K. K., Latour A. M., Malouf N. N., Boucher R. C., Smithies O., Koller B. H. An animal model for cystic fibrosis made by gene targeting. Science. 1992 Aug 21;257(5073):1083–1088. doi: 10.1126/science.257.5073.1083. [DOI] [PubMed] [Google Scholar]
  13. Wilcken B., Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet. 1985 Dec 14;2(8468):1319–1321. doi: 10.1016/s0140-6736(85)92623-6. [DOI] [PubMed] [Google Scholar]
  14. Wilson J. M. Principles of screening for disease. Proc R Soc Med. 1971 Dec;64(12):1255–1256. doi: 10.1177/003591577106401238. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES